CLIMB BIO, INC. (CLYM)
Climb Bio, Inc. Announces $110.0 Million Private Placement
Climb Bio, Inc. Announces $110.0 Million Private Placement
BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
LGI Homes, Inc. Reports First Quarter 2026 Results and Raises Full Year Margin Guidance
One and One Green Technologies Reports Strong 2025 Financial Results With 82% Increase in Net Income
Gogo to Report First Quarter 2026 Financial Results on 7 May, 2026
CD&R Announces Jim Lico, Former Fortive CEO, as Operating Advisor
Polestar Decouples Growth From Negative Climate Impact: Emissions Per Sold Car Cut by 31% in Five Years
Asbury Automotive Group Reports First Quarter Results
Honeywell Announces Board of Directors for Honeywell Aerospace
Stepan Reports First Quarter 2026 Results